CMS Expands Oversight and Competition Among Organ Procurement Organizations

Key Takeaways

• The Centers for Medicare & Medicaid Services (CMS) finalized changes to organ procurement organization oversight, clarifying decertification authority and allowing high-performing organizations to compete for multiple service areas.
• Updated requirements address adverse events, research-organ documentation, and performance measurement while supporting continuity during transitions between organizations.
• The rule takes effect January 2, 2027; processes for certifying and designating new organizations remain subject to future rulemaking.

CMS finalized a rule October 30, 2026, revising the Organ Procurement Organizations Conditions for Coverage to strengthen accountability and help more donated organs reach patients. The rule, CMS-3409-F, updates oversight, competition, and operational requirements for organ procurement organizations (OPOs).^1,2

OPOs coordinate donation authorization, organ recovery, and delivery between donor hospitals and transplant programs. CMS reported that more than 49 000 transplants occurred in 2025, while more than 100 000 Americans remain on the transplant waiting list.¹

What Changes Under the OPO Final Rule?

The rule clarifies “unsound medical practices,” establishing a clearer basis for CMS to exercise its existing authority to immediately decertify a noncompliant OPO. It also strengthens expectations for identifying, investigating, and preventing adverse events.¹

Performance measurement changes distinguish research activity from transplantation. A donor whose pancreas is recovered solely for islet cell research continues to count toward the donation rate, but the pancreas does not count toward the transplantation rate unless transplanted. OPOs must also document the disposition of organs recovered for research.³

How Will Competition and Service-Area Transitions Work?

The final rule retains the existing 3-tier performance framework. Tier 1 service areas meet the upper benchmark on both donation and transplantation measures. Tier 2 areas meet the lower benchmark on both measures but fall short of tier 1; their OPOs must compete to retain them. OPOs whose service areas are all tier 3 will be decertified and cannot compete for another open area.²

High-performing OPOs may compete for multiple donation service areas. To support continuity when responsibility changes, outgoing organizations must cooperate with successors, and incoming OPOs must submit transition plans and periodic progress reports to CMS.^1,2

The rule also formalizes discretionary CMS Administrator review of hearing officer decisions and revises appeals timelines.³

What Does the Rule Mean for Managed Care?

For payers and managed care organizations, these provisions suggest practical areas to monitor: continuity of organ procurement operations during service-area changes, communication with transplant partners, and whether revised performance measures provide a clearer picture of organs reaching patients. These are operational considerations inferred from the rule’s requirements, rather than demonstrated improvements in access or spending.

Becker’s Hospital Review reported estimated implementation costs of $16.5 million in the first year and $7.9 million annually thereafter. These figures describe regulatory implementation costs and should not be interpreted as projected payer savings.³

What Happens Next?

The rule takes effect January 2, 2027. Although it removes an older restriction on OPO certification, the American Hospital Association noted that CMS has not established processes for certifying or designating new OPOs and intends to address those processes through future rulemaking.⁴

For managed care stakeholders, implementation will be an opportunity to assess whether stronger oversight and transition requirements translate into more reliable procurement operations and improved transplant access.

References

1. Centers for Medicare & Medicaid Services. CMS finalizes rule to help more organs reach patients and strengthen accountability for organ procurement organizations. Published October 30, 2026. Accessed November 6, 2026. https://ag.state.la.us/Article/430 and https://aglizmurrill.com/Article/288 
2. Centers for Medicare & Medicaid Services. Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage, Final Rule (CMS 3409-F). Published October 30, 2026. Accessed November 6, 2026. https://www.cms.gov/newsroom/fact-sheets/medicare-medicaid-programs-organ-procurement-organizations-conditions-coverage-revisions-conditions
3. Bean M. CMS tightens oversight of organ procurement groups: 7 notes. Becker’s Hospital Review. Published October 30, 2026. Accessed November 6, 2026. https://www.beckershospitalreview.com/quality/patient-safety-outcomes/cms-finalizes-organ-procurement-organization-oversight-rule-7-notes/
4. American Hospital Association. CMS issues final rule on oversight of organ procurement organizations. Published November 2, 2026. Accessed November 6, 2026. https://www.aha.org/news/headline/2026-11-02-cms-issues-final-rule-oversight-organ-procurement-organizations